Hormonal regulation of the expression of Mmp15, a proteolytic enzyme indispensable for ovulation in the teleost medaka, was investigated. In an in vitro culture system using 25 preovulatory follicles, Mmp15 expression and ovulation were induced in the presence of recombinant luteinizing hormone (rLh). Both rLh-induced Mmp15 expression and ovulation were 17α, 20β-dihydroxy-4-pregnen-3-one-dependent, suggesting the involvement of a nuclear progestin receptor (Pgr). In vitro follicle ovulation and 
Introduction
Ovulation denotes the shedding of one or more viable oocytes from fully grown ovarian follicles into the reproductive tract and is triggered by the binding of gonadotropin luteinizing hormone (LH) to the receptor in the follicle cells of the follicles destined to 50 ovulate (Richards, 1994; Ma et al., 2004; Espey and Richards, 2006; Lubzens et al., 2010; Zhang et al., 2015; Takahashi et al., 2016) . This process is accomplished through a highly regulated cascade of endocrine, morphological, and biochemical events (Espey and Richards, 2006) . It is well known that follicle rupture in vertebrate ovulation involves proteolytic degradation at the apical region of ovulating follicles. In the teleost 55 medaka, a variety of proteolytic enzymes are expressed in the follicles (Takahashi et al., 2013) . Our previous studies demonstrated that the sequential actions of two distinct proteolytic enzyme systems, the plasminogen activator/plasmin (Plau/plasmin) system and the matrix metalloproteinase (Mmp) system, are required for the hydrolysis of extracellular matrix (ECM) proteins present in the follicle layers of ovulating follicles 60 (Ogiwara et al., 2005; Ogiwara et al., 2012; Ogiwara et al., 2015) . In the first step of ECM hydrolysis, active plasmin is produced by the proteolytic processing of liver-derived precursor plasminogen through the follicle-produced active plasminogen activator-1 (Plau1). Plasmin, thus activated, hydrolyzes laminin, a major ECM component constituting the basement membrane (Ogiwara et al., 2012; Ogiwara et al., 65 2015) . As a second step, another proteolytic system involving membrane type 1-Mmp (Mt1-mmp/Mmp14), membrane type 2-Mmp (Mt2-mmp/Mmp15), and gelatinase A (Mmp2) is activated. Mmp2, which is activated by Mmp14 and hydrolyzes type IV collagen, another principal component of the basement membrane, and Mmp15 degrade the type I collagen present in the theca cell layer (Ogiwara et al., 2005) . Activation of 70 4 the Plau/plasmin system and the Mmp system in the follicle is regulated by plasminogen activator inhibitor-1 (Ogiwara et al., 2015) and the tissue inhibitor of metalloproteinase-2b (Ogiwara et al., 2005) , respectively. Interestingly, among the proteolytic enzymes involved in the process, Mmp15 alone was shown to be drastically induced with recombinant medaka Lh in the granulosa cells of ovulating follicles at the 75 time of ovulation (Ogiwara et al., 2013) . This suggests that Mmp15 may be an ovulation-related protein whose expression is under the control of LH in the fish.
However, at present, it is not known how the mmp15 gene expression would be controlled in the granulosa cells of the follicles that have undergone a surge of LH.
The aim of the present study was to gain information on the mechanism underlying 80 the LH-induced expression of mmp15/Mmp15 in the preovulatory follicles that are destined to ovulate. Our results indicate that the LH-induced expression of the mmp15 gene is accomplished in two steps: Pgr is first induced by an LH surge, and the resulting Pgr subsequently may serve as a transcription factor for the expression of mmp15 mRNA and protein. This study suggests that the transcription factor 85 CCAAT/enhancer-binding protein β (Cebpb) is also involved in mmp15 gene expression.
Materials and Methods

Animals and tissues 90
Adult orange-red variant medaka, Oryzias latipes, were purchased from a local dealer and used for experiments. Maintenance and acclimation of the fish to the artificial reproductive conditions (14 h light and 10 h dark, 26-27°C) were conducted as previously described (Hagiwara et al., 2014) . Under these conditions, the fish ovulated 5 every day around the transition time from the dark to the light period. In the present 95 study, ovulation hour 0 was set to the start of the light period. Ovaries, ovarian follicles, and follicle layers of the follicles were isolated from the spawning female fish as previously described (Ogiwara et al., 2013) . Animal cultures and experimentation were conducted in accordance with the guidelines for animal experiments of Hokkaido University and were approved by the Committee of Experimental Plants and Animals, 100
Hokkaido University.
In vitro culture of dissected follicles
The culture was performed as previously described (Ogiwara et al., 2013) . The outline of in vitro follicle culture is shown in Fig. 1 . Follicles, which had not yet been exposed 105 to the in vivo surge of LH, were isolated at 22 h before ovulation from ovaries of the fish with established 24-h spawning cycle and were cultured in 4 ml of 90% M199 medium containing 50 μM gentamycin (pH 7.4). The follicles were obtained from two to three fish ovaries, pooled, and then divided into control and test groups. The isolated follicles (approximately 20-25 follicles per group) were cultured with 100 µg/ml 110 medaka recombinant LH (rLh), 25 µM trilostane (TLS, Sigma-Aldrich, St. Louis, MO), 1 µM 17α, 20β-dihydroxy-4-pregnen-3-one (17, 20βP, Sigma-Aldrich), or 0.1 mM RU-486 (also known as mifepristone, Sigma-Aldrich). The duration of incubation and the time points when the follicles and/or follicle layers were collected for analysis of the expression levels of target genes are shown in Fig. 1 . The rate of follicle ovulation was 115 determined after the follicles were cultured for 30 h. Medaka rLh was produced in Chinese hamster ovary k-1 cells as previously described (Hagiwara et al., 2014) . 6 2.3. RNA isolation, reverse transcription (RT), and real-time polymerase chain reaction (PCR) 120
Total RNA isolation, RT, and real-time PCR were conducted as previously described (Fujimori et al., 2011) , except that a Thermal Cycler Dice ® Real-Time II MRQ (Takara Bio. Osaka, Japan) was used for analyses. Cytoplasmic actin (actb) was used as a reference gene to normalize the expression of the target genes examined. The primers used in this study are listed in Supplemental Table S1 . 125
Preparation of antigens and antibodies
A 858-bp cDNA coding for the complete Cebpb protein (286 residues) was amplified by RT-PCR using KOD Neo DNA polymerase (Toyobo, Tokyo, Japan) with ovary cDNA.
The amplified product was phosphorylated and ligated into the vector pET30a 130 (Novagen, Madison, WI), which had been previously digested by EcoRV. The protein antigen was produced in the bacterial expression system. Expression, purification, and dialysis of the protein were performed as previously described (Ogiwara and Takahashi, 2007) . Anti-medaka Cebpb antibody was generated using mice according to the method previously described (Ogiwara et al., 2013) . Recombinant Pgr was produced as 135 described previously (Hagiwara et al., 2014) and used to immunize rats to obtain anti-medaka Pgr antibody. Mouse anti-medaka Pgr antibody (Hagiwara et al., 2014) , rabbit anti-medaka Mmp15 antibody (Ogiwara and Takahashi, 2007) , and rabbit anti-medaka Actb antibody (Ogiwara et al., 2012) were prepared as described previously.
Antibodies were purified using an Immobilon polyvinylidene difluoride (PVDF) 140 (Millipore, Bedford, MA) membrane as described (Ogiwara et al., 2012) , and the resulting purified antibodies were used for the experiments. Large preovulatory follicles that were isolated from ovaries at various time points or 145 follicles that were pre-cultured in vitro with rLh were homogenized in buffer A (50 mM Tris-HCl buffer (pH 8.0), 0.15 M NaCl, 1% Triton X-100, and 0.1% SDS) containing 1×protease inhibitor cocktail (Wako, Osaka, Japan) and 1×phosphatase inhibitor cocktail (Wako), and subsequently incubated at 4°C for 2 h with agitation. After incubation, the follicles were centrifuged at 15,500 × g for 10 min, and the resultant 150 supernatants were used for immunoprecipitation. Immunoprecipitation was performed as previously described (Ogiwara et al., 2005) with the following modifications. The samples (3 mg each) were treated with Protein G-Sepharose (GE Healthcare, Buckinghamshire, England) that had been previously coupled with specific antibodies or normal IgG. After incubation at 4°C for 16 h, they were washed with buffer A three 155 times, followed by 50 mM Tris-HCl (pH 8.0) twice. The precipitant materials were boiled in 1×SDS sample buffer for 20 min and used for western blot analyses. The input was loaded with 2% of the extracts used for immunoprecipitation experiments. Normal IgG served as a negative control. Protein concentrations of the samples were determined using a Pierce BCA Protein Assay Reagent kit (Thermo Fisher Scientific, San Jose, 160 CA).
Western blot analysis
Gel electrophoresis and the transfer to Immobilon PVDF membranes (Millipore) were performed according to standard procedure. To detect the materials immunoprecipitated 165 with rat anti-medaka Pgr antibody, western blot analyses were carried out as follows.
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The membranes onto which the proteins were transferred were blocked using Block Ace (Dainippon Sumitomo Seiyaku Inc., Osaka, Japan) at room temperature for 1 h and then reacted with mouse anti-medaka Pgr antibody at room temperature for 1 h. After the membrane was washed with PBS containing 0.1% Tween-20 four times, it was 170 incubated with an ImmunoCruz TM IP/WB Optima E System (SantaCruz, Dallas, Texas) according to the manufacturer's instructions. Signals were detected using an Immobilon Western kit (Millipore). Actb was detected as a positive control. 2.7. 5'-rapid amplification of cDNA end (RACE) 175 5'-RACE was performed to determine putative transcription start sites for medaka mmp15 gene. Total RNAs were prepared from ovaries obtained at 3 h before ovulation and were subjected to RT using an Mmp15-GSP-1 primer (Supplemental Table S1 ). A homopolymeric tail was subsequently added to the 3'-end of the synthesized cDNA and used as a template for PCR. Two rounds of PCR were carried out using the 180 Mmp15-GSP-2 or Mmp15-GSP-3 primers, and the amplified products were subcloned into a pBluescript II SK (+) and were sequenced. Sequence information for mmp15 that had been previously submitted to NCBI was updated.
Luciferase assay 185
A nucleotide corresponding to a region including the partial mmp15 gene promoter (−948 to −1) was amplified by PCR using KOD Neo DNA polymerase with genomic DNA purified from the liver. The primer pair used were Mmp15-Luc SS and Mmp15-Luc AS (Supplemental Table S1 ). The PCR product was phosphorylated and ligated into the pGL3 firefly luciferase expression vector (Promega Corporation, 190 9 Madison, Germany), which had been previously digested by SmaI. The resultant vector, pGL3-Mmp15, was confirmed by DNA sequencing. The cDNA coding for the complete Cebpb protein was amplified by the RT-PCR described above. The amplified product was phosphorylated and ligated into the vector pCMV tag4, which had been previously digested by EcoRV. The resultant vector, pCMV-Cebpb, was confirmed by DNA 195 sequencing. Luciferase assay, construction of pCMV-Pgr vector, cell culture for 293T cells, and transfection were performed as previously described (Hagiwara et al., 2014) .
Briefly, pCMV-Pgr, pGL3-Mmp15, pRL mock, and either pCMV tag4 (mock) or pCMV-Cebpb were co-transfected into 293T cells. After 24 h culture, the cells were added to fresh medium with or without 1 mM 17,20βP and further cultured for 24 h. 200
The cells were then harvested and luciferase activity was measured. 
Chromatin immunoprecipitation (ChIP)
ChIP assays were performed as previously described (Hagiwara et al., 2014) . Briefly, 215 preovulatory follicles were isolated from the fish ovaries at 4, 10, 15, and 23 h before ovulation. Follicle layer cell fractions obtained from the follicles were fixed and lysed.
The fractions were later sonicated and immunoprecipitated with Protein G-Sepharose (GE Healthcare) that had been previously treated with mouse anti-medaka Pgr antibody or mouse anti-Cebpb. Nonimmune immunoglobulin G was used as a negative control. 220
After immunoprecipitation, precipitates were washed, eluted, and reverse-crosslinked.
The extracted DNA was analyzed by real-time PCR. To design PCR primers, a search for the sequence corresponding to the 5'-flanking regions of the mmp15 and cebpb gene was carried out using the Ensembl medaka genome database (Ensembl database). Eight sets of primers were designed (Supplemental Table S1 ) and synthesized. As a negative 225 control for real-time PCR, primer pairs were set 6-7 kbp upstream of a putative transcription start site. Putative binding sites of transcription factors were searched for using a free program TFBIND (TFBIND [Internet] ; Tsunoda and Takagi, 1999).
Statistical analysis 230
The experiments performed in this study were repeated four to six times, and the results are presented as the mean ± S.E.M. Statistical data analyses were performed using a t-test, or one-way ANOVA followed by Dunnett's or Tukey's post hoc test, as appropriate. Equal variation was confirmed by F-test or Bartlett's test, as appropriate. P values less than 0.05 were considered statistically significant. For western blot analyses 235 and immunoprecipitation/western blot analyses, the reproducibility of the results was confirmed after repeating the experiment three to four times, and the results of one 11 experiment are presented.
Results 240
3.1. Involvement of 17,20βP in LH-induced expression of Mmp15 in the preovulatory follicle of the medaka ovary
We previously reported that treatment of preovulatory follicles that had not been exposed to LH in vivo with medaka recombinant LH (rLh) in vitro significantly increased the expression of Mmp15 (Ogiwara et al., 2013) . Using this experimental 245 system, we confirmed that rLh induces the expression of mmp15 mRNA in the follicles ( Fig. 2A) . We further examined the effects of trilostane (TLS), an inhibitor of 3β-hydroxysteroid dehydrogenase (Potts et al., 1978) , and 17α, 20β-dihydroxy-4-pregnen-3-one (17,20βP), the maturation-inducing hormone in the medaka (Sakai et al., 1987) , on the follicular expression of the MMP gene and protein. 250
When the follicles were incubated with rLh in the presence of TLS, rLh was not found to induce mmp15 expression. Further, TLS-suppressed mmp15 mRNA expression was considerably restored by adding 17,20βP into the culture. The effects of these substances on Mmp15 were examined at the protein level, and the results were consistent with those of mmp15 mRNA expression (Fig. 2B ). TLS treatment drastically 255 inhibited rLh-induced follicle ovulation, while the addition of 17,20βP in the culture could block the ovulation-suppression effect of TLS (Fig. 2C ). Following identification of 17,20βP as a factor playing a role in Mmp15 expression in the follicles, we examined whether 17,20βP could directly stimulate the expression of Mmp15. In one experiment, preovulatory follicles, which had not yet been exposed to the in vivo surge of LH, were 260 isolated 22 h before ovulation and then incubated in the presence of both rLh and 17,20βP. In another experiment, the follicles, which had been exposed to the in vivo surge of LH, were isolated 12 h before ovulation and were incubated with 17,20βP. No significant change in the temporal Mmp15 expression patterns of the follicles was seen by externally adding the steroid hormone in both experiments. 265 Overall, the above results strongly suggest that 17,20βP is involved in the LH-induced expression of Mmp15 in the follicles that are destined to ovulate.
Effect of RU-486 on the expression of Mmp15 in the preovulatory follicle
In a preliminary experiment, we found that rLh-induced expression of mmp15 mRNA 270 and the Mmp15 protein in the preovulatory follicles was inhibited in the follicles co-cultured with RU-486, which was previously shown to act as an antagonist for medaka Pgr (Hagiwara et al., 2014) . This implied that Pgr, but not the membrane progestin receptor, may play a role in the Mmp15 expression in the follicles at ovulation. M RU-486 demonstrated follicle ovulation that was suppressed by 90% (Hagiwara et al., 2014) . At this concentration of the antagonist, the level of rLh-stimulated mmp15 mRNA 280 expression in the follicles was significantly reduced (Fig. 3A) . Interestingly, the reduced follicular expression level of mmp15 mRNA by RU-486 was restored to that observed with rLh-treated follicles if 17,20βP was added to the culture together with the antagonist. As shown by western blot analysis (Fig. 3B) , RU-486 treatment of the follicles inhibited rLh-stimulated expression of Mmp15, while the inclusion of both 285 13 RU-486 and 17,20βP in the culture resulted in expression levels of Mmp15 that were comparable to that of the follicles treated with rLh alone. The effect of RU-486 on the follicular expression of mmp15/Mmp15 was examined using the follicles that had been already exposed to the in vivo surge of LH. When the follicles isolated 12 h before ovulation were incubated for 18 h with RU-486, the expression of both mmp15 mRNA 290 and protein was significantly reduced (Fig. 4) ; these results were consistent with those obtained of follicles treated in vitro with both rLh and RU-486 (Fig. 3A) .
Next, the effect of RU-486 treatment of the preovulatory follicles on the expression of Pgr was examined. The in vivo expression of the Pgr protein in the preovulatory follicles was increased at 15 h before ovulation and sustained thereafter (Fig. 5A ). The 295 follicles, which were isolated from the fish ovary at 22 h before ovulation, were cultured in vitro in the presence of rLh. Under this condition, Pgr protein levels became detectable around 9 h after the start of incubation (Fig. 5B ), confirming our previous results (Hagiwara et al., 2014 ). Neither the pgr transcript level nor the protein level were affected by the addition of RU-486 ( Fig. 5C and 5D ), indicating that RU-486 had 300 no effect on the Lh-induced expression of Pgr itself.
The above results are indicative of participation of Pgr in the expression of Mmp15 in the follicles undergoing ovulation.
Binding of Pgr to the promoter region of the mmp15 gene 305
To examine whether Pgr would be involved in the expression of the mmp15 gene in the preovulatory follicles, ChIP assays were performed using the Pgr antibody. We searched putative binding sites of Pgr and found nucleotide sequences showing partial homology to progesterone response element (PRE) at eight sites in the 1.5 kb upstream region of 14 the transcription site of the mmp15 gene. In the assay, we initially used eight primer 310 pairs, seven of which were set in the above 1.5 kb promoter region at intervals of approximately 30-170 bp to amplify the regions including each of the Pgr binding sites.
Among the eight primer pairs used (Fig. 6A) , primer pair-1 and pair-2 were successful at amplifying an expected 101 and 210 bp nucleotide, respectively, when preovulatory follicles were isolated from the fish ovary 4 h before ovulation (Fig. 6B) . Preovulatory 315 follicles isolated 23, 15, 10, and 4 h before ovulation were used for the ChIP experiments using primer pair-1. Pgr recruitment to the promoter was observed for the follicles isolated 4 h before ovulation (Fig. 6C) . We further examined the effect of Pgr on the expression of mmp15 using OLHNI-2 cells, a cell line established using cells that originated from the medaka fin. When the cells stably expressing Pgr were treated with 320 17,20βP for 24 h, a significant increase in mmp15 expression was observed (Fig. 6D Knowing that the mmp15 gene expression may be under the control of the transcription factor Pgr in the ovulating follicle, an important question arises on the timing of the expression of these two genes. The expression of pgr mRNA peaks at 11 h before 330 ovulation (Hagiwara et al., 2014) , while mmp15 mRNA becomes detectable at 2 h before ovulation (Ogiwara et al., 2005) . We therefore conducted experiments to gain insights into the mechanism by which the onset of transcription of the mmp15 gene 15 takes time as long as approximately 9 h after pgr gene expression. We hypothesized that, in addition to Pgr, some other transcription factor(s) may play a role for the expression 335 of mmp15 gene in the follicle, and that the 9-h time lag may represent the time required for the induction of such a factor(s). In our attempts to search transcription factors that might be involved in the mmp15 gene expression, we found that cebpb mRNA expression increased in the preovulatory follicles in association with ovulation. The time course of cebpb mRNA levels was investigated using the preovulatory follicles 340 isolated from the fish ovaries at various time points of the 24-h spawning cycle. Levels of cebpb mRNA remained low between 23 h and 15 h before ovulation, but cebpb expression levels increased as ovulation approached (Fig. 7A) . When preovulatory follicles isolated from the fish ovaries 22 h before ovulation were cultured with rLh, levels of cebpb mRNA increased (Fig. 7B) . To detect Cebpb protein in the follicle, a 345 mouse anti-medaka Cebpb antibody was raised in this study. Recombinant medaka Cebpb (rCebpb) was prepared in the E. coli expression system (Fig. 7C, left panel) . rCebpb was used as an antigen on immunization of the animal. The antibody recognized the antigen, but the antibody previously treated with rCebpb no longer detected the antigen (Fig. 7C, right panel) , indicating that our Cebpb antibody was specific. Western 350 blot analysis showed a single band at a position of approximately 43 kDa with the extracts of follicle layers of preovulatory follicles isolated between −7 h and −3 h of ovulation (Fig. 7D) ; these results were consistent with those of cebpb mRNA (Fig. 7A) .
We next examined the possibility that Cebpb directly binds to the promoter region of the medaka mmp15 gene. We found numerous putative binding sites of Cebpb in the 355 2.0 kb upstream region of the transcription site of the mmp15 gene (Fig. 6A) . ChIP assays were performed using a specific antibody for medaka Cebpb with preovulatory follicles isolated 4 h before ovulation in a way similar to the ChIP experiment for Pgr.
Significant enrichment was observed with primer pair-1 and pair-7 (Fig. 8A) . ChIP assays were further conducted with the preovulatory follicles isolated 10 h and 4 h 360 before ovulation using primer pair-1, primer pair-7, and primer pair-8 (control). The expected nucleotide fragment was amplified in follicles obtained 4 h before ovulation with primer pair-1 and primer pair-7 (Fig. 8B) . We further examined the effects of Pgr Furthermore, ChIP assays were performed using Pgr antibody with preovulatory follicles isolated 4 h before ovulation. PCR using the precipitated materials with primer sets that were designed and synthesized according to the nucleotide sequence corresponding to the 5′-flanking region of the medaka cebpb gene (Ensembl database), 380 did not yield any amplified fragment (data not shown). The results suggest that the induced expression of the cebpb gene occurred in a Pgr-independent manner.
The above results suggest that mmp15 expression is regulated by both 17,20βP-associated Pgr and Cebpb.
385
Discussion
In the present study, an in vivo interaction of Pgr with the mmp15 gene promoter was experimentally demonstrated. None of the eight PRE-like sequences found in the 5′ upstream region appeared to yield a palindromic sequence that could form a hairpin-like structure. No potential PRE half-site (5′-TGTTCT-3′) was found in the region either. 390
These considerations tempt us to speculate that Pgr may not bind to the 5′ upstream region of the medaka mmp15 gene. Previous studies indicated that complexed Pgr could be tethered indirectly to other transcription factors that bind to the DNA binding sites on promoters of progesterone-regulated genes (Jacobsen and Horwitz, 2012). Taking these into consideration, we tentatively speculate that Pgr-dependent expression of the mmp15 395 gene in the medaka preovulatory follicles with impending ovulation may result from an intimate interaction between Pgr and other key transcription factor(s) in the promoter region of the gene. In this process, Pgr may act as an inducible co-regulator for the factors, which has been previously proposed as the role of Pgr in Pgr-regulated gene expression in mammalian ovaries (Robker et al., 2009 ). To establish the validity of this 400 assumption, further studies are required, including identification of the key factor(s) that interact with Pgr. This study is now underway in our laboratory.
As revealed by ChIP analysis, the binding of Cebpb could occur at two distinct sites in the promoter region of the mmp15 gene. These two regions contain several putative A large number of Pgr-regulated, ovulation-related genes induced by LH have been identified in mammals (Espey and Richards, 2006; Kim et al., 2009; Mishra et al., 2015; 440 Robker et al., 2009) . Existing evidence also indicates increases in transcript and/or protein abundance of various genes at or around the time of ovulation in teleosts (Bobe et al., 2006; Garczynski and Goetz, 1997; Nagahama, 1997; Nagahama and Yamashita, 2008: Takahashi et al., 2013; von Schalburg et al., 2005; Zmora et al., 2007) , but to date, no investigations have been conducted examining whether Pgr might be involved in the 445 induced expression of such genes. However, our previous (Hagiwara et al., 2014 ) and present data demonstrate an indispensable role for Pgr in LH-induced expression of the ptger4b and mmp15 genes, respectively. A critical role of Pgr as a mediator in the process of signal transductions from LH surge to the expression of various ovulation-related genes in the preovulatory follicles at ovulation remains to be verified 450 in other non-vertebrate animals, including amphibians, reptiles, and aves; however, it is safe to propose that the role of Pgr in the expression of some, if not all, genes necessary for successful ovulation is conserved across vertebrate species from fish to humans.
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Substantial evidence has accumulated to indicate the essential role of Cebpb in ovulation in rodents (Sirois and Richards, 1993; Sterneck et al., 1997) . Cebpb was 455 reported to be increased by LH in the preovulatory follicles of the mouse (Fan et al., 2009) , and targeted disruption of the Cebpb gene was shown to cause a failure in ovulation (Sterneck et al., 1997) . More recently, it has been demonstrated that the expression and functional activation of both Cebpb and Cebpa in the granulosa cells are essential for LH-, cAMP/PKA-, and ERK1/2-mediated events associated with ovulation 460 in the mouse (Fan et al., 2011) . Our current study demonstrates that, as in the case of the mouse, Cebpb expression is LH-inducible in the preovulatory follicles of the fish, and exhibits an important role in fish ovulation. At present, there is no information on the signaling processes from LH stimulation of the follicles to the cebpb gene expression in the medaka. Precise signaling cascades leading to Cebpb expression in the 465 LH-stimulated follicles would be worthy of being studied to understand the mechanism of vertebrate ovulation from an evolutional point of view.
In summary, this study explored the mechanisms of mmp15 mRNA and Mmp15 expression by employing an in vitro follicle ovulation system in medaka. Our data indicate that Mmp15 expression is dramatically induced by rLh-and Pgr-dependent 470 mechanisms in the preovulatory follicles that are destined to ovulate. This work also demonstrates the involvement of the transcription factor Cebpb in Mmp15 expression.
The present study supports the idea that Pgr plays a critical role in the expression of some, if not all, ovulation-related genes, not only in mammalian species but also in fish. Sterneck, E., Tassarollo, L., Johnson, P.F., 1997. An essential role for C/EBPβ in female reproduction. Genes Dev. 11, 2153 Dev. 11, -2162 Takahashi, A., Kanda, S., Abe, T., Oka, Y., 2016. Evolution of the hypothalamic-pituitary-gonadal axis regulation in vertebrates revealed by knockout medaka. Endocrinol. 157, 3994-4002. doi:10.1210 Endocrinol. 157, 3994-4002. doi:10. /en.2016 Endocrinol. 157, 3994-4002. doi:10. -1356 Takahashi, T., Fujimori, C., Hagiwara, A., Ogiwara, K., 2013 . Recent advances in the understanding of teleost medaka ovulation: the role of proteases and prostaglandins.
Zool. Sci. 30, 239-247. doi: 10.2108/zsj.30 Preovulatory follicles were isolated from ovaries at 22 h before ovulation and incubated with rLh (100 μg/ml). The follicles were collected every 3 h to prepare tissue extracts. were used for the ChIP assays using the primer pairs 1 to 7. The sheared DNA that was immunoprecipitated with mouse anti-medaka Pgr antibody was analyzed by real-time PCR. As a negative control, the assay was also performed using primer pair 8 (P-8). 
